Abbott Settlement With DOJ Highlights Feds’ Anti-Fraud Efforts
This article was originally published in The Gray Sheet
Abbott will pay $5.47 million to resolve allegations that it paid physicians for teaching assignments, speaking engagements and conferences with the expectation that they would in return facilitate product purchases at their hospitals.
You may also be interested in...
A former Guidant salesman alleged the company marketed biliary stents off-label for use in vascular procedures. However, the company said Medicare knew biliary stents were the standard of care for arterial uses. A Texas jury sided with Abbott.
HHS Secretary Kathleen Sebelius is resigning, and Office of Management and Budget Director Sylvia Mathews Burwell has been nominated to take over her cabinet post, President Obama announced April 11.
The settlement addresses allegations by the Justice Department that the company provided kickbacks to Medicare customers and physicians from 1998 to 2006 to purchase brachytherapy seeds used to treat prostate cancer.